Emcure Pharmaceuticals Ltd. - Research Center
544210 EMCURE Group (B) BSE data
Add to watchlist
| Results | |
| Statement |
P&L
|
| More |
Profit loss account
(Rs crore)
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Income | |||||
| Operating income | 3,497.66 | 3,107.09 | 3,387.24 | 3,153.66 | 2,375.71 |
| Expenses | |||||
| Material consumed | 1,362.97 | 1,325.27 | 1,414.61 | 1,326.45 | 892.22 |
| Manufacturing expenses | 88.73 | 80.41 | 72.46 | 73.92 | 67.29 |
| Personnel expenses | 706.41 | 649.18 | 603.95 | 550.96 | 545.35 |
| Selling expenses | 261.47 | 150.83 | 114.73 | 80.55 | 121.67 |
| Adminstrative expenses | 636.19 | 462.90 | 386.83 | 378.38 | 325.76 |
| Expenses capitalised | - | - | - | - | - |
| Cost of sales | 3,055.76 | 2,668.59 | 2,592.57 | 2,410.26 | 1,952.29 |
| Operating profit | 441.89 | 438.49 | 794.67 | 743.41 | 423.42 |
| Other recurring income | 138.26 | 125.35 | 132.68 | 111.91 | 137.62 |
| Adjusted PBDIT | 580.15 | 563.84 | 927.35 | 855.31 | 561.04 |
| Financial expenses | 166.09 | 166.83 | 145.14 | 123.34 | 137.22 |
| Depreciation | 204.83 | 178.52 | 165.79 | 156.24 | 154.97 |
| Other write offs | - | - | - | - | - |
| Adjusted PBT | 209.23 | 218.48 | 616.42 | 575.74 | 268.84 |
| Tax charges | 39.08 | 52.28 | 169.61 | 136.97 | 49.48 |
| Adjusted PAT | 170.15 | 166.21 | 446.81 | 438.76 | 219.36 |
| Non recurring items | -14.65 | -2.08 | -0.79 | -18.18 | -46.19 |
| Other non cash adjustments | - | - | - | - | - |
| Reported net profit | 155.50 | 164.12 | 446.02 | 420.59 | 173.17 |
| Earnigs before appropriation | 1,749.34 | 1,630.01 | 2,323.13 | 1,895.19 | 1,522.88 |
| Equity dividend | 54.26 | 36.17 | 54.26 | 18.09 | 42.15 |
| Preference dividend | - | - | - | - | - |
| Dividend tax | - | - | - | - | 3.06 |
| Retained earnings | 1,695.08 | 1,593.84 | 2,268.88 | 1,877.11 | 1,477.67 |
© 2025 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis